These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36067)

  • 1. Prevention and treatment of space sickness in shuttle-orbiter missions.
    Graybiel A
    Aviat Space Environ Med; 1979 Feb; 50(2):171-6. PubMed ID: 36067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of experimental motion sickness by scopolamine absorbed through the skin.
    Graybiel A; Knepton J; Shaw J
    Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe motion sickness with antimotion sickness drug injections.
    Graybiel A; Lackner JR
    Aviat Space Environ Med; 1987 Aug; 58(8):773-6. PubMed ID: 3632537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevention of motion sickness in orbital flight.
    Graybiel A
    Life Sci Space Res; 1976; 14():109-18. PubMed ID: 11977268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of effectiveness of some antimotion sickness drugs using recommended and larger than recommended doses as tested in the slow rotation room. NSAM-945.
    Wood CD; Graybiel A; Kennedy RS
    Res Rep U S Nav Sch Aviat Med; 1965 Jul; ():1-9. PubMed ID: 5322559
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment efficacy of intramuscular promethazine for space motion sickness.
    Davis JR; Jennings RT; Beck BG; Bagian JP
    Aviat Space Environ Med; 1993 Mar; 64(3 Pt 1):230-3. PubMed ID: 8447805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coping with space motion sickness in Spacelab missions.
    Graybiel A
    Acta Astronaut; 1981; 8(9-10):1015-8. PubMed ID: 11543090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of treatment strategies for Space Motion Sickness.
    Davis JR; Jennings RT; Beck BG
    Microgravity Q; 1992 Jul; 2(3):173-7. PubMed ID: 11541442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness.
    Wood CD; Stewart JJ; Wood MJ; Manno JE; Manno BR; Mims ME
    Aviat Space Environ Med; 1990 Feb; 61(2):157-61. PubMed ID: 2178599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of antimotion sickness drug side effects on performance.
    Wood CD; Manno JE; Manno BR; Redetzki HM; Wood MJ; Mims ME
    Aviat Space Environ Med; 1985 Apr; 56(4):310-6. PubMed ID: 3888169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of antimotion sickness drugs.
    Wood CD; Manno JE; Wood MJ; Manno BR; Redetzki HM
    Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A262-5. PubMed ID: 3675502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea.
    Noy S; Shapira S; Zilbiger A; Ribak J
    Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head movements in non-terrestrial force environments elicit motion sickness: implications for the etiology of space motion sickness.
    Lackner JR; Graybiel A
    Aviat Space Environ Med; 1986 May; 57(5):443-8. PubMed ID: 3707473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new antinauseant drug for the prevention of motion sickness.
    Graybiel A; Knepton J
    Aviat Space Environ Med; 1977 Sep; 48(9):867-71. PubMed ID: 334151
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions.
    Wood CD; Graybiel A
    Aerosp Med; 1968 Dec; 39(12):1341-4. PubMed ID: 4881887
    [No Abstract]   [Full Text] [Related]  

  • 16. Human assay of antimotion sickness drugs.
    Graybiel A; Wood CD; Knepton J; Hoche JP; Perkins GF
    Aviat Space Environ Med; 1975 Sep; 46(9):1107-18. PubMed ID: 1100039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of simulator sickness in an AH-64 aviator.
    Kroll JD
    Aviat Space Environ Med; 1989 Dec; 60(12):1202-3. PubMed ID: 2604677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual differences in susceptibility to motion sickness among six Skylab astronauts.
    Graybiel A; Miller EF; Homick JL
    Acta Astronaut; 1975; 2(1-2):155-74. PubMed ID: 11841091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of anti-motion sickness drugs in the squirrel monkey.
    Cheung BS; Money KE; Kohl RL; Kinter LB
    J Clin Pharmacol; 1992 Feb; 32(2):163-75. PubMed ID: 1613127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motion-sickness medications for aircrew: impact on psychomotor performance.
    Paul MA; MacLellan M; Gray G
    Aviat Space Environ Med; 2005 Jun; 76(6):560-5. PubMed ID: 15945400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.